PortfoliosLab logoPortfoliosLab logo
HIMS vs. IESC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HIMS vs. IESC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and IES Holdings, Inc. (IESC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HIMS achieves a 3.30% return, which is significantly lower than IESC's 94.01% return.


HIMS

1D
-5.44%
1M
41.22%
YTD
3.30%
6M
-4.31%
1Y
-47.77%
3Y*
58.52%
5Y*
24.71%
10Y*

IESC

1D
5.94%
1M
14.42%
YTD
94.01%
6M
86.85%
1Y
176.33%
3Y*
142.78%
5Y*
70.62%
10Y*
52.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HIMS vs. IESC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
HIMS
Hims & Hers Health, Inc.
3.30%34.28%171.69%38.85%-2.14%-55.14%47.47%1.23%
IESC
IES Holdings, Inc.
94.01%93.58%153.67%122.72%-29.76%9.99%79.42%28.17%

Correlation

The correlation between HIMS and IESC is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2019

0.25

Fundamentals

Market Cap

HIMS:

$7.66B

IESC:

$15.24B

EPS

HIMS:

-$0.05

IESC:

$18.85

PS Ratio

HIMS:

3.47

IESC:

4.19

PB Ratio

HIMS:

17.17

IESC:

14.20

Total Revenue (TTM)

HIMS:

$2.37B

IESC:

$3.63B

Gross Profit (TTM)

HIMS:

$1.70B

IESC:

$931.31M

EBITDA (TTM)

HIMS:

$16.04M

IESC:

$487.14M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HIMS vs. IESC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
HIMS Risk / Return Rank: 2222
Overall Rank
HIMS Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2525
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2525
Omega Ratio Rank
HIMS Calmar Ratio Rank: 1919
Calmar Ratio Rank
HIMS Martin Ratio Rank: 2121
Martin Ratio Rank

IESC
IESC Risk / Return Rank: 9393
Overall Rank
IESC Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IESC Sortino Ratio Rank: 8888
Sortino Ratio Rank
IESC Omega Ratio Rank: 8989
Omega Ratio Rank
IESC Calmar Ratio Rank: 9797
Calmar Ratio Rank
IESC Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIMS vs. IESC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and IES Holdings, Inc. (IESC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HIMSIESCDifference
Sharpe ratioReturn per unit of total volatility

-3.30

Sortino ratioReturn per unit of downside risk

-3.20

Omega ratioGain probability vs. loss probability

0.97

1.39

-0.43

Calmar ratioReturn relative to maximum drawdown

-0.61

8.14

-8.75

Martin ratioReturn relative to average drawdown

-1.00

23.00

-24.00

HIMS vs. IESC - Sharpe Ratio Comparison

The current HIMS Sharpe Ratio is -0.49, which is lower than the IESC Sharpe Ratio of 2.81. The chart below compares the historical Sharpe Ratios of HIMS and IESC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HIMS vs. IESC - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, smaller than the maximum IESC drawdown of -98.32%. Use the drawdown chart below to compare losses from any high point for HIMS and IESC.


Loading charts...

Drawdown Indicators


HIMSIESCDifference

Max Drawdown

Largest peak-to-trough decline

-87.29%

-98.32%

+11.03%

Max Drawdown (1Y)

Largest decline over 1 year

-78.06%

-21.80%

-56.26%

Max Drawdown (3Y)

Largest decline over 3 years

-78.88%

-49.23%

-29.65%

Max Drawdown (5Y)

Largest decline over 5 years

-78.88%

-54.22%

-24.66%

Max Drawdown (10Y)

Largest decline over 10 years

-54.28%

Current Drawdown

Current decline from peak

-51.21%

0.00%

-51.21%

Average Drawdown

Average peak-to-trough decline

-43.26%

-54.94%

+11.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

48.60%

7.70%

+40.90%

Volatility

HIMS vs. IESC - Volatility Comparison

Hims & Hers Health, Inc. (HIMS) has a higher volatility of 23.38% compared to IES Holdings, Inc. (IESC) at 16.76%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than IESC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HIMSIESCDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.38%

16.76%

+6.62%

Volatility (6M)

Calculated over the trailing 6-month period

69.21%

49.73%

+19.48%

Volatility (1Y)

Calculated over the trailing 1-year period

97.84%

63.28%

+34.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.58%

54.25%

+29.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.39%

48.18%

+29.21%

Dividends

HIMS vs. IESC - Dividend Comparison

Neither HIMS nor IESC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HIMS vs. IESC - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and IES Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
608.10M
974.20M
(HIMS) Total Revenue
(IESC) Total Revenue
Values in USD except per share items

HIMS vs. IESC - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and IES Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20222023202420252026
65.3%
24.5%
Portfolio components
HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

IESC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IES Holdings, Inc. reported a gross profit of 238.70M and revenue of 974.20M. Therefore, the gross margin over that period was 24.5%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

IESC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IES Holdings, Inc. reported an operating income of 112.30M and revenue of 974.20M, resulting in an operating margin of 11.5%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.

IESC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IES Holdings, Inc. reported a net income of 110.00M and revenue of 974.20M, resulting in a net margin of 11.3%.


Frequently Asked Questions


HIMS and IESC have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HIMS has higher volatility (23.38%) compared to IESC (16.76%). In terms of maximum drawdown, HIMS dropped -87.29% vs IESC's -98.32%.

IESC currently has the higher Sharpe Ratio (2.81 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HIMS and IESC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer